Latest News

Solve President and CEO Emily Taylor, Chief Scientific Officer H. Timothy Hsiao, and Director of Advancement Ilise Friedman recently visited Yale School of Medicine’s Center for Infection & Immunity (CII), the Center Director, Sterling Professor Akiko Iwasaki, and her research team, as coordinated by Dr. Nicole Darricarrère, CII’s Scientific Program Director, in New Haven, CT. The Solve delegation honored Professor Iwasaki with an award to recognize her contributions to the study of infection-associated chronic conditions and illnesses, and delivered an invited talk to the Iwasaki Lab to elaborate the power of the Solve Together Real-World Platform to accelerate biomedical research for post-acute infection syndromes, such as ME/CFS and Long Covid.

Yale Cancer Center scientists and trainees attended the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago May 31-June 4 to present research advances from Yale Cancer Center and Smilow Cancer Hospital. The ASCO meeting is the most significant gathering of oncology professionals worldwide, initiating connections and forging collaborations that can change the landscape of cancer care.

The results of this trial, an overall response rate of 56.5% and a response rate of 75% at the highest dose level, are impressive for CAR-T therapy for a solid tumor, to be sure, said Sidi Chen, a cancer researcher at Yale Cancer Center who was not involved with the work.

Yale Cancer Center and Smilow Cancer Hospital people who have been honored

In a new study, published in the American Journal of Respiratory and Critical Care Medicine, researchers used single-cell RNA sequencing to measure the gene expressions of individual peripheral blood mononuclear cells in patients with progressive IPF, patients with stable IPF, and lung-disease-free patients. Previously, the researchers had studied bulk samples of these cells but not examined them individually and in detail.

Yale researchers who conducted the largest human brain analysis from a single-cell perspective hope their findings lead to better prediction of medicine that will target certain cells.

An international group of experts led by the Yale School of Public Health has proposed adding two sub-classifications to the current dengue virus nomenclature to help identify and track strains of potential epidemiologic or clinical importance.

Amos S. Espinosa, a PhD Candidate in Experimental Pathology, was recently named a winner of the American Society of Hematology's Minority Hematology Graduate Award.

The Kavli Institute for Neuroscience is pleased to announce the recipients of the 2024 Kavli Postdoctoral Fellowship: Drs. Hongyan Hao, Kevin Chen, and Dhananjay Bhaskar.